Send this to a friend

Swiss firm licenses gene therapies from UMass Medical School

A Swiss company developing gene therapies for neurological diseases has licensed programs researched at UMass Medical School in Worcester.
The therapies are meant to treat Tay-Sachs and Sandhoff diseases, two rare and similar inherited conditions. Research on the therapies was developed by a team of researchers at UMass Medical School, including Miguel Sena-Esteves, Heather Gray-Edwards and Terence Flotte, the dean of the School of Medicine.

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media